Your browser doesn't support javascript.
loading
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer.
Liao, John B; Swensen, Ron E; Ovenell, Kelsie J; Hitchcock-Bernhardt, Katie M; Reichow, Jessica L; Apodaca, Minjun C; D'Amico, Leonard; Childs, Jennifer S; Higgins, Doreen M; Buening, Barbara J; Goff, Barbara A; Disis, Mary L.
Affiliation
  • Liao JB; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United
  • Swensen RE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United
  • Ovenell KJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United
  • Hitchcock-Bernhardt KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United
  • Reichow JL; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
  • Apodaca MC; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
  • D'Amico L; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
  • Childs JS; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
  • Higgins DM; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
  • Buening BJ; Seattle Cancer Care Alliance, 825 Eastlake Ave. E., Seattle, WA 98109, United States.
  • Goff BA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States.
  • Disis ML; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
Gynecol Oncol ; 144(3): 480-485, 2017 03.
Article in En | MEDLINE | ID: mdl-28089377
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2017 Document type: Article Country of publication: